Abiopharma

🔍 Dixon Robert Michael (Executive)

Company: CPI Card Group Inc. (PMTS)

Report Date: 2026-08-29

Detailed Transactions and Holdings:

• Acquired 524 shares of Common Stock (Direct)
  Date: 2026-08-29 | Code: M | equity_swap_involved: 0 | shares_owned_after: 9,271.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 158 shares of Common Stock at $28.83 per share (Direct)
  Date: 2026-08-29 | Code: F | equity_swap_involved: 0 | shares_owned_after: 9,113.00 | transaction_form_type: 4 | Footnotes: F2
• Acquired 154 shares of Common Stock (Direct)
  Date: 2026-08-30 | Code: M | equity_swap_involved: 0 | shares_owned_after: 9,267.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 47 shares of Common Stock at $28.83 per share (Direct)
  Date: 2026-08-30 | Code: F | equity_swap_involved: 0 | shares_owned_after: 9,220.00 | transaction_form_type: 4 | Footnotes: F2
• Acquired 740 shares of Common Stock (Direct)
  Date: 2026-08-31 | Code: M | equity_swap_involved: 0 | shares_owned_after: 9,960.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 223 shares of Common Stock at $28.97 per share (Direct)
  Date: 2026-08-31 | Code: F | equity_swap_involved: 0 | shares_owned_after: 9,737.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 524 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-29 | Code: M | equity_swap_involved: 0 | shares_owned_after: 1,042.00 | transaction_form_type: 4 | Footnotes: F1, F3, F3
• Sold 154 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-30 | Code: M | equity_swap_involved: 0 | shares_owned_after: 154.00 | transaction_form_type: 4 | Footnotes: F1, F4, F4
• Sold 740 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-31 | Code: M | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F5, F5
• Acquired 1,362 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-31 | Code: A | equity_swap_involved: 0 | shares_owned_after: 1,362.00 | transaction_form_type: 4 | Footnotes: F1, F6, F6

Footnotes:

• F1: Each restricted stock unit ("RSU") represents the right to receive one common share of the Issuer upon vesting of such RSU.
• F2: Shares withheld by Issuer to satisfy the mandatory tax withholding requirement upon vesting RSUs. Not an open market sale of securities.
• F3: This line reports RSUs that were awarded on the August 29, 2025 award date, which vested on the first anniversary of the award date. The remaining RSUs granted on the award date will vest in substantially equal installments on the second and third anniversaries of the award date, subject to the reporting person's continued service through such date or as otherwise provided for in the applicable award agreement.
• F4: This line reports RSUs that were awarded on the August 30, 2024 award date, which vested in substantially equal installments on the first and second anniversaries of the award date. The remaining RSUs granted on the award date will vest in a substantially equal installment on the third anniversary of the award date, subject to the reporting person's continued service through such date or as otherwise provided for in the applicable award agreement.
• F5: This line reports the remaining RSUs that were awarded on the August 31, 2023 award date, which vested in substantially equal installments on the first, second and third anniversaries of the award date.
• F6: Represents a restricted stock unit award which vests in three substantially equal installments on August 31, 2027, 2028, and 2029, subject to the reporting person's continued service through such date or as otherwise provided for in the applicable award agreement.